HK Stock MarketDetailed Quotes

HM INTL HLDGS (08416)

Watchlist
  • 0.141
  • 0.0000.00%
Trading May 20 09:00 CST
59.42MMarket Cap7.42P/E (TTM)

HM INTL HLDGS (08416) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
181.25%8.18M
----
-253.78%-10.07M
----
-11.17%6.55M
----
92.18%7.37M
----
181.68%3.83M
----
Profit adjustment
Interest (income) - adjustment
55.54%-453K
----
-76.60%-1.02M
----
-679.73%-577K
----
-335.29%-74K
----
66.67%-17K
----
Attributable subsidiary (profit) loss
----
----
----
----
23.44%-356K
----
62.20%-465K
----
-345.02%-1.23M
----
Impairment and provisions:
-88.93%394K
----
-6.39%3.56M
----
168.69%3.8M
----
-49.55%1.42M
----
-16.79%2.81M
----
-Impairment of trade receivables (reversal)
-4.60%394K
----
11.32%413K
----
198.93%371K
----
-168.81%-375K
----
-83.83%545K
----
-Impairment of goodwill
----
----
-8.31%3.15M
----
91.68%3.43M
----
-20.80%1.79M
----
--2.26M
----
Revaluation surplus:
----
----
----
----
----
----
----
----
-111.84%-322K
----
-Other fair value changes
----
----
----
----
----
----
----
----
-111.84%-322K
----
Asset sale loss (gain):
-9,497.62%-3.95M
----
100.68%42K
----
-36,494.12%-6.19M
----
-95.47%17K
----
650.00%375K
----
-Loss (gain) from sale of subsidiary company
---3.95M
----
----
----
---6.39M
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
----
1,300.00%42K
----
-82.35%3K
----
-95.47%17K
----
504.84%375K
----
-Loss (gain) from selling other assets
----
----
----
----
--198K
----
----
----
----
----
Depreciation and amortization:
-38.53%7.06M
----
-7.83%11.48M
----
-9.64%12.45M
----
-7.47%13.78M
----
3.96%14.89M
----
-Amortization of intangible assets
-52.31%155K
----
-71.11%325K
----
-1.23%1.13M
----
22.60%1.14M
----
255.94%929K
----
Financial expense
-4.37%919K
----
38.27%961K
----
-0.14%695K
----
-58.67%696K
----
-45.97%1.68M
----
Special items
-82.04%183K
----
148.54%1.02M
----
--410K
----
----
----
----
----
Operating profit before the change of operating capital
106.34%12.33M
----
-64.40%5.98M
----
-26.18%16.79M
----
3.25%22.74M
----
33.62%22.02M
----
Change of operating capital
Accounts receivable (increase)decrease
-313.41%-14.31M
----
55.58%6.7M
----
99.21%4.31M
----
124.91%2.16M
----
-216.69%-8.68M
----
Accounts payable increase (decrease)
1,312.85%17.56M
----
-183.65%-1.45M
----
161.67%1.73M
----
-243.95%-2.81M
----
129.87%1.95M
----
Special items for working capital changes
124.56%2.82M
----
-192.51%-11.46M
----
362.72%12.39M
----
-188.27%-4.72M
----
239.45%5.34M
----
Cash  from business operations
8,064.94%18.4M
----
-100.66%-231K
----
102.63%35.22M
----
-15.77%17.38M
----
8.78%20.63M
----
Other taxs
96.60%-7K
----
81.15%-206K
----
-614.38%-1.09M
----
-116.79%-153K
----
147.80%911K
----
Special items of business
----
151.48%3.16M
----
-212.96%-6.13M
----
-31.89%5.43M
----
27.25%7.97M
----
376.85%6.26M
Net cash from operations
4,308.70%18.39M
151.48%3.16M
-101.28%-437K
-212.96%-6.13M
98.08%34.12M
-31.89%5.43M
-20.05%17.23M
27.25%7.97M
26.27%21.55M
376.85%6.26M
Cash flow from investment activities
Interest received - investment
-55.54%453K
----
76.60%1.02M
----
679.73%577K
----
335.29%74K
----
-66.67%17K
----
Decrease in deposits (increase)
----
----
----
----
397.24%1.51M
----
---507K
----
----
----
Sale of fixed assets
----
----
1,800.00%19K
----
-90.00%1K
----
--10K
----
----
----
Purchase of fixed assets
94.81%-483K
----
-831.50%-9.32M
----
5.57%-1M
----
10.25%-1.06M
----
-114.55%-1.18M
----
Purchase of intangible assets
39.53%-78K
----
-115.00%-129K
----
89.69%-60K
----
10.46%-582K
----
72.77%-650K
----
Sale of subsidiaries
--3.68M
----
----
----
--16.45M
----
----
----
----
----
Acquisition of subsidiaries
----
----
----
----
---1.91M
----
----
----
-90.56%259K
----
Other items in the investment business
----
98.70%-102K
----
-178.77%-7.87M
----
49.28%-2.82M
----
-223.49%-5.56M
----
65.55%-1.72M
Net cash from investment operations
142.46%3.57M
98.70%-102K
-153.98%-8.41M
-178.77%-7.87M
854.41%15.57M
49.28%-2.82M
-32.82%-2.06M
-223.49%-5.56M
59.36%-1.55M
65.55%-1.72M
Net cash before financing
348.34%21.96M
121.81%3.05M
-117.80%-8.84M
-637.48%-14M
227.75%49.69M
8.36%2.6M
-24.16%15.16M
-47.08%2.4M
51.01%19.99M
223.40%4.54M
Cash flow from financing activities
New borrowing
----
----
----
----
----
----
--2.62M
----
----
----
Refund
-8.84%-234K
----
67.67%-215K
----
68.14%-665K
----
---2.09M
----
----
----
Interest paid - financing
4.37%-919K
----
-38.27%-961K
----
0.14%-695K
----
58.67%-696K
----
45.97%-1.68M
----
Dividends paid - financing
----
----
-33.33%-8.43M
----
-110.70%-6.32M
----
---3M
----
----
----
Other items of the financing business
----
81.79%-2.65M
----
-241.74%-14.58M
----
40.42%-4.27M
---485K
-4.74%-7.16M
----
-18.54%-6.83M
Net cash from financing operations
68.27%-5.44M
81.79%-2.65M
2.31%-17.15M
-241.74%-14.58M
-13.27%-17.55M
40.42%-4.27M
-15.52%-15.5M
-4.74%-7.16M
48.73%-13.42M
-18.54%-6.83M
Effect of rate
-2,026.32%-366K
-17,000.00%-169K
112.84%19K
100.69%1K
-886.67%-148K
---145K
34.78%-15K
----
-228.57%-23K
----
Net Cash
163.55%16.52M
101.40%399K
-180.87%-25.99M
-1,620.11%-28.57M
9,693.73%32.14M
65.07%-1.66M
-105.09%-335K
-107.37%-4.76M
150.88%6.58M
75.72%-2.29M
Begining period cash
-28.68%64.6M
-28.68%64.6M
54.61%90.58M
54.61%90.58M
-0.59%58.59M
-0.59%58.59M
12.51%58.94M
12.51%58.94M
-19.80%52.38M
-19.80%52.38M
Cash at the end
25.00%80.76M
4.56%64.83M
-28.68%64.6M
9.21%62.01M
54.61%90.58M
4.80%56.78M
-0.59%58.59M
8.17%54.18M
12.51%58.94M
-10.35%50.09M
Cash balance analysis
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 181.25%8.18M-----253.78%-10.07M-----11.17%6.55M----92.18%7.37M----181.68%3.83M----
Profit adjustment
Interest (income) - adjustment 55.54%-453K-----76.60%-1.02M-----679.73%-577K-----335.29%-74K----66.67%-17K----
Attributable subsidiary (profit) loss ----------------23.44%-356K----62.20%-465K-----345.02%-1.23M----
Impairment and provisions: -88.93%394K-----6.39%3.56M----168.69%3.8M-----49.55%1.42M-----16.79%2.81M----
-Impairment of trade receivables (reversal) -4.60%394K----11.32%413K----198.93%371K-----168.81%-375K-----83.83%545K----
-Impairment of goodwill ---------8.31%3.15M----91.68%3.43M-----20.80%1.79M------2.26M----
Revaluation surplus: ---------------------------------111.84%-322K----
-Other fair value changes ---------------------------------111.84%-322K----
Asset sale loss (gain): -9,497.62%-3.95M----100.68%42K-----36,494.12%-6.19M-----95.47%17K----650.00%375K----
-Loss (gain) from sale of subsidiary company ---3.95M---------------6.39M--------------------
-Loss (gain) on sale of property, machinery and equipment --------1,300.00%42K-----82.35%3K-----95.47%17K----504.84%375K----
-Loss (gain) from selling other assets ------------------198K--------------------
Depreciation and amortization: -38.53%7.06M-----7.83%11.48M-----9.64%12.45M-----7.47%13.78M----3.96%14.89M----
-Amortization of intangible assets -52.31%155K-----71.11%325K-----1.23%1.13M----22.60%1.14M----255.94%929K----
Financial expense -4.37%919K----38.27%961K-----0.14%695K-----58.67%696K-----45.97%1.68M----
Special items -82.04%183K----148.54%1.02M------410K--------------------
Operating profit before the change of operating capital 106.34%12.33M-----64.40%5.98M-----26.18%16.79M----3.25%22.74M----33.62%22.02M----
Change of operating capital
Accounts receivable (increase)decrease -313.41%-14.31M----55.58%6.7M----99.21%4.31M----124.91%2.16M-----216.69%-8.68M----
Accounts payable increase (decrease) 1,312.85%17.56M-----183.65%-1.45M----161.67%1.73M-----243.95%-2.81M----129.87%1.95M----
Special items for working capital changes 124.56%2.82M-----192.51%-11.46M----362.72%12.39M-----188.27%-4.72M----239.45%5.34M----
Cash  from business operations 8,064.94%18.4M-----100.66%-231K----102.63%35.22M-----15.77%17.38M----8.78%20.63M----
Other taxs 96.60%-7K----81.15%-206K-----614.38%-1.09M-----116.79%-153K----147.80%911K----
Special items of business ----151.48%3.16M-----212.96%-6.13M-----31.89%5.43M----27.25%7.97M----376.85%6.26M
Net cash from operations 4,308.70%18.39M151.48%3.16M-101.28%-437K-212.96%-6.13M98.08%34.12M-31.89%5.43M-20.05%17.23M27.25%7.97M26.27%21.55M376.85%6.26M
Cash flow from investment activities
Interest received - investment -55.54%453K----76.60%1.02M----679.73%577K----335.29%74K-----66.67%17K----
Decrease in deposits (increase) ----------------397.24%1.51M-------507K------------
Sale of fixed assets --------1,800.00%19K-----90.00%1K------10K------------
Purchase of fixed assets 94.81%-483K-----831.50%-9.32M----5.57%-1M----10.25%-1.06M-----114.55%-1.18M----
Purchase of intangible assets 39.53%-78K-----115.00%-129K----89.69%-60K----10.46%-582K----72.77%-650K----
Sale of subsidiaries --3.68M--------------16.45M--------------------
Acquisition of subsidiaries -------------------1.91M-------------90.56%259K----
Other items in the investment business ----98.70%-102K-----178.77%-7.87M----49.28%-2.82M-----223.49%-5.56M----65.55%-1.72M
Net cash from investment operations 142.46%3.57M98.70%-102K-153.98%-8.41M-178.77%-7.87M854.41%15.57M49.28%-2.82M-32.82%-2.06M-223.49%-5.56M59.36%-1.55M65.55%-1.72M
Net cash before financing 348.34%21.96M121.81%3.05M-117.80%-8.84M-637.48%-14M227.75%49.69M8.36%2.6M-24.16%15.16M-47.08%2.4M51.01%19.99M223.40%4.54M
Cash flow from financing activities
New borrowing --------------------------2.62M------------
Refund -8.84%-234K----67.67%-215K----68.14%-665K-------2.09M------------
Interest paid - financing 4.37%-919K-----38.27%-961K----0.14%-695K----58.67%-696K----45.97%-1.68M----
Dividends paid - financing ---------33.33%-8.43M-----110.70%-6.32M-------3M------------
Other items of the financing business ----81.79%-2.65M-----241.74%-14.58M----40.42%-4.27M---485K-4.74%-7.16M-----18.54%-6.83M
Net cash from financing operations 68.27%-5.44M81.79%-2.65M2.31%-17.15M-241.74%-14.58M-13.27%-17.55M40.42%-4.27M-15.52%-15.5M-4.74%-7.16M48.73%-13.42M-18.54%-6.83M
Effect of rate -2,026.32%-366K-17,000.00%-169K112.84%19K100.69%1K-886.67%-148K---145K34.78%-15K-----228.57%-23K----
Net Cash 163.55%16.52M101.40%399K-180.87%-25.99M-1,620.11%-28.57M9,693.73%32.14M65.07%-1.66M-105.09%-335K-107.37%-4.76M150.88%6.58M75.72%-2.29M
Begining period cash -28.68%64.6M-28.68%64.6M54.61%90.58M54.61%90.58M-0.59%58.59M-0.59%58.59M12.51%58.94M12.51%58.94M-19.80%52.38M-19.80%52.38M
Cash at the end 25.00%80.76M4.56%64.83M-28.68%64.6M9.21%62.01M54.61%90.58M4.80%56.78M-0.59%58.59M8.17%54.18M12.51%58.94M-10.35%50.09M
Cash balance analysis
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More